BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lange F, Rateitschak K, Kossow C, Wolkenhauer O, Jaster R. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach. World J Gastroenterol 2012; 18(43): 6226-6234 [PMID: 23180942 DOI: 10.3748/wjg.v18.i43.6226]
URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6226.htm
Number Citing Articles
1
X.Y. Lan, H.Y. Sun, J.J. Liu, Y. Lin, Z.Y. Zhu, X. Han, X. Sun, X.R. Li, H.C. Zhang, Z.Y. Tang. Effects of Garlic Oil on Pancreatic Cancer CellsAsian Pacific Journal of Cancer Prevention 2013; 14(10): 5905 doi: 10.7314/APJCP.2013.14.10.5905
2
Mohamed A. Omar, Jürgen Conrad, Uwe Beifuss. Assembly of 4H-chromenes, imidazobenzothiazines and quinazolines via copper-catalyzed domino reactions using 2-halobenzyl tosylates as substratesTetrahedron 2014; 70(35): 5682 doi: 10.1016/j.tet.2014.06.071
3
Seong Joon Park, Seung-Mi Kim, Jai-Hee Moon, Jeong Hee Kim, Jae-Sik Shin, Seung-Woo Hong, Yu Jin Shin, Dae-Hee Lee, Eun Young Lee, Ih-Yeon Hwang, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Won–Keun Lee, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim. SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherinTumor Biology 2016; 37(4): 4323 doi: 10.1007/s13277-015-4216-2
4
Mohamed A. Omar, Jürgen Conrad, Uwe Beifuss. Copper-catalyzed domino reaction between 1-(2-halophenyl)methanamines and amidines or imidates for the synthesis of 2-substituted quinazolinesTetrahedron 2014; 70(18): 3061 doi: 10.1016/j.tet.2014.02.066
5
K Kajiyama, M Okada-Hatakeyama, Y Hayashizaki, H Kawaji, H Suzuki. Capturing Drug Responses by Quantitative Promoter Activity ProfilingCPT: Pharmacometrics & Systems Pharmacology 2013; 2(9): 77 doi: 10.1038/psp.2013.53
6
C S Monast, M J Lazzara. Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational ModelingCPT: Pharmacometrics & Systems Pharmacology 2014; 3(10): 141 doi: 10.1038/psp.2014.39
7
Changyi Chen. Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicineMedical Science Monitor 2013; 19: 916 doi: 10.12659/MSM.889636
8
Falko Lange, Benjamin Franz, Claudia Maletzki, Michael Linnebacher, Maja Hühns, Robert Jaster. Biological and Molecular Effects of Small Molecule Kinase Inhibitors on Low-Passage Human Colorectal Cancer Cell LinesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/568693
9
Prashant Dogra, Javier R. Ramírez, María J. Peláez, Zhihui Wang, Vittorio Cristini, Gulshan Parasher, Manmeet Rawat. Mathematical Modeling to Address Challenges in Pancreatic CancerCurrent Topics in Medicinal Chemistry 2020; 20(5): 367 doi: 10.2174/1568026620666200101095641
10
Kovuru Gopalaiah, Anupama Saini, Alka Devi. Iron-catalyzed cascade reaction of 2-aminobenzyl alcohols with benzylamines: synthesis of quinazolines by trapping of ammoniaOrganic & Biomolecular Chemistry 2017; 15(27): 5781 doi: 10.1039/C7OB01159H
11
Jing Du, Yuanqiao He, Weiquan Wu, Peng Li, Youwei Chen, Zhiming Hu, Yong Han. Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancerJournal of Pharmacy and Pharmacology 2019; 71(2): 196 doi: 10.1111/jphp.12941
12
Julio Vera, Olaf Wolkenhauer, Ulf Schmitz. eLS2014;  doi: 10.1002/9780470015902.a0025237
13
Christian Klopsch, Anna Skorska, Marion Ludwig, Heiko Lemcke, Gabriela Maass, Ralf Gaebel, Martin Beyer, Cornelia Lux, Anita Toelk, Karina Müller, Christian Maschmeier, Sarah Rohde, Petra Mela, Brigitte Müller-Hilke, Stefan Jockenhoevel, Brigitte Vollmar, Robert Jaster, Robert David, Gustav Steinhoff. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heartDisease Models & Mechanisms 2018;  doi: 10.1242/dmm.033282